Dr Rod Passman (Northwestern Memorial Hospital, Chicago, IL, US) talks about “pill-in-pocket” anticoagulation for atrial fibrillation. In this short summary, he compares the results of the REACT.COM and TACTIF-AF pilot studies and discusses the REACT-AF study.
The REACT-AF poses the question of whether we can leverage the advances in both wearable technology and pharmacology with a rapid onset novel or direct anticoagulants.
Recorded remotely from Chicago, 2021.
Editor: Mirjam Boros